key: cord-0996800-svcx9btf authors: Santos, Lucas Gomes; da Silva, Regicley Vieira; Leal, Thiago Cavalcanti; Xavier, José Emerson; Figueiredo, Elaine Virgínia Martins de Souza; de Paiva, João Paulo Silva; da Silva, Leonardo Feitosa; Rocha, Carlos Alberto de Oliveira; Nunes, Bruno Eduardo Bastos Rolim; Santana, Gibson Barros de Almeida; Fernandes, Tânia Rita Moreno de Oliveira; Costa, Francisco de Assis; Bezerra-Santos, Márcio; Feliciano do Carmo, Rodrigo; Armstrong, Anderson da Costa; de Souza, Carlos Dornels Freire title: Impact of the COVID-19 pandemic on hospital admissions and in-hospital lethality from cardiovascular diseases in Brazil: an ecological and time series study COVID-19 and cardiovascular diseases date: 2022-04-21 journal: Curr Probl Cardiol DOI: 10.1016/j.cpcardiol.2022.101216 sha: fbdf32f268f398fd3fa09db5b421b76f2afde954 doc_id: 996800 cord_uid: svcx9btf BACKGROUND: Since the onset of the coronavirus disease 2019 (COVID-19) pandemic in Brazil, several government policies have been taken. Herein, we aimed to assess the impact of the COVID-19 pandemic on hospital admissions and in-hospital lethality for cardiovascular diseases (CVD) in Brazil in 2020. METHODS: An ecological and time-series study on hospitalizations and deaths from CVD in Brazil was conducted from January 2018 to December 2020. RESULTS: The hospital admission rate for CVD reduced by 17.1%, with a significantly decreasing trend between January and May 2020 (Annual Percent Change: -8,7%; p-value <0.001). The in-hospital lethality rate increased from 8.2% in 2018 to 9.3% in 2020. During this period, Brazil totaled 21.8 million days of hospital stay. CONCLUSION: Indicators of hospital admissions and lethality from CVD in Brazil were impacted by the emergence of the COVID-19 pandemic in different ways in the regions and depending on the nature of the indicator. Paulo in a patient from Italy, but the disease rapidly spread to the large metropolises of other regions until it reached smaller and more distant cities [5] [6] [7] . Despite all WHO recommendations, and the enactment of Law No. 13 .979/2020 on February 7, 2020 (which provides for measures to combat COVID-19 in the country), restrictive measures for the movement of people, such as banning events with agglomeration in several states and closing all non-essential commerce were only implemented in late March 8 . As a result, in July 2020 the first wave of the pandemic was observed in the country, with a daily average of 70 thousand new cases of COVID-19. To date, Brazil ranks second in the world in number of deaths by COVID-19 9 . Remarkable, the COVID-19 pandemic has been causing significant impacts on public health and the global economy. Furthermore, the measures to restrict the mobility of people and the redirection of health services to fight the transmission of the virus have also affected the control of several other diseases such as cancer, dementia, and high blood pressure 10-12 . Additionally, this impact occurs directly, in patients with any comorbidity, especially chronic diseases; and indirectly, by changing the behavior of the population, such as fear of contagion and reduced demand for health services 11, 13 . Importantly, the implementation of collective measures of social distancing to contain COVID-19 resulted in changes in the routine of services. As a result, this promoted the rescheduling of elective procedures and the redistribution of hospital flow to transform faceto-face hospital care into distance care (tele-health) in several clinical situations 14 . To illustrate this impact, in an oncology center in São Paulo, there was a reduction of 45% in the number of patients treated and 57.4% in the number of patients undergoing systemic intravenous treatment 10 . Clinically, there is an important relationship between COVID-19 and cardiovascular diseases (CVD), such as: i. the impact of CVD on the worsening of COVID-19, which is an relevant set of predictors of severity and mortality 15 ; ii. the damage caused by SARS-CoV-2 in the cardiovascular system (CS) of people without underlying disease due to pathophysiological mechanisms of virus infection 16 ; and iii. the worsening of CVD in individuals without COVID-19, but as a result of non-pharmacological preventive measures to reduce the circulation of the virus, such as hospital evasion of patients, delaying the care of episodes of exacerbation of these chronic conditions or making early diagnosis difficult 11, 16 . Herein, we aimed to assess the impact of the COVID-19 pandemic on hospital admissions and in-hospital lethality for CVD in Brazil during the first year of the pandemic. An ecological and time-series study was conducted on hospitalizations and deaths from CVD in Brazil and its regions from January 2018 to December 2020. Data on CVD for the years 2018 and 2019 were used as the period before the COVID-19 pandemic and were compared with data for 2020. Herein, the following variables were assessed: i. hospital admissions rate for CVD (Chapter IX of the ICD-10) per month (from January 2018 to December 2020); ii. in-hospital lethality rate due to CVD per month (from January 2018 to December 2020); iii. total cost applied (in Brazilian reais -R$) and average cost (R$) of hospitalizations for CVD; iv. days of hospital stay and average time of stay (in days) for CVD; v. new COVID-19 cases registered per month. To calculate the rates, the following equations were applied: i. hospital admissions rate for CVD = 10,000 ii. in-hospital lethality rate due to CVD The statistical analysis of the data took place in three steps: This study used data from the public domain, which does not allow the identification of the subjects. For this reason, the appreciation of the Research Ethics Committee was waived. (Table 1) . The in-hospital lethality rate for CVD in Brazil was 8.2% in 2018, 8.3% in 2019, and 9.3% in 2020 (12.5% increase compared to 2019). Differently from what was observed in the hospitalization rate, the in-hospital lethality rate in Brazil showed an increase of 21.3% in April 2020, with a peak in May (25%) and with percentages above 12% in all other months of the year (Figure 2A ). Among this period, the North region had the highest lethality rates in 2018 and 2019 (9.2% and 9.8%, respectively). In 2020, the highest rate was identified in the Central-west region (10.7%). On the other hand, the South region showed the lowest rates (6.4% in 2018, 6 .5% in 2019, and 7.63% in 2020) ( Figure 2B-F) . Additionally, the North region showed the biggest increase in the lethality rate (+31.45%) between the months of February and June 2020, followed by the Northeast region, with a peak of lethality in May (+11.76%) ( Figure 2G ). Importantly, we observed an increasing trend in the lethality rate in Brazil between p-value <0.001) showed an increasing trend during the first half of 2020 (Table 2) . During the study period, R$8.8 billion were spent on hospitalizations for CVD throughout Brazil, with an average cost of R$2.6 thousand per each hospitalization. The highest cost was observed in 2019 (R$3.1 billion) and the lowest in 2020 (total cost of R$2.8 billion − a reduction of 10.3%). In addition, there was reduction in total cost from April (-15.8%) to December 2020 ( Figure 3A) . Conversely, the average cost of each hospitalization ranges from R$2.6 to R$2.8 thousand reais (an increase of 7.4%). Moreover, there was increase in every month of 2020, mainly in March (+5.4%), August (+11.5%), and December (+13.3%) ( Figure 4A ). As expected, the highest hospitalization costs were identified in the Southeast region Table 3 and 4) . There was a total of 21.8 million days of hospitalization for CVD in Brazil (annual average of 7.3 million) between 2018 and 2020. During this period, the average length of stay was 6.5 days. In 2020, there was a reduction of 17.1% in the total period of hospitalizations and a reduction of 1.5% in the average length of stay. With the onset of the pandemic, there was a significant reduction in the total period of hospitalizations, mainly in July (-27.2%) and August 2020 (-27.6%) (Figure 5 and 6 ). In the study period, the Southeast region showed the highest number of days of hospitalization with CVD (annual average of 3.4 million days) and the North has the lowest (344.9 thousand days). As of April 2020, all regions showed a reduction in the sum of days. In addition, the North was the region with the greatest reduction in 2020 (-20.7%) ( Figure 5) . The average length of stay was longer in the Northeast region (7.2 days) and shorter in the South (5.4 days) ( Figure 6) . Table 5) . Regarding the average number of days of stay, there was a stationary trend in the country (AAPC: 0.0). Also, there was an increasing trend in the Northeast (AAPC: 0.2; p-value <0.001) and a reduction in the North region (AAPC: -1.0; p-value < 0.001) ( Table 6 ). Initially, the pandemic caused important changes in the behavior of the population, which may have resulted in reduced access to health services. Likewise, the need for social distancing to control the spread of the virus seems to have acted as a factor generating fear of contamination in health facilities 19 . Additionally, there was reduction of urban mobility and access to health services by the population. Taken together, these factors may have influenced the evasion of patients from different health services, whether in primary care, responsible for managing risk factors-chronic diseases, or in specialized-hospital centers 10, 11, 20 . Similarly, the reduction in hospitalizations for CVD was also observed in other studies worldwide 21, 22 . Corroborating our findings, a study conducted in New York (USA) observed a significant reduction in acute hospitalizations for chronic diseases in 2020, including cardiovascular diseases 23 . Importantly, the delay in patient care, observed in many countries, has resulted in serious clinical conditions rarely seen outside this context, such as cardiogenic shock and ventricular rupture due to acute myocardial infarction (AMI), which significantly increases risk of death from CVD 24 . In Brazil, an investigation carried out with more than 45 thousand individuals showed that people with CVD had greater adherence to measures of social distancing 25 . Remarkable, this scenario can be justified by different factors, such as: i. association between the presence of CVD and increased risk of death from COVID-19 26 ; ii. the fear of SARS-CoV-2 infection 27 ; iii. the amount of information disseminated by the media and social networks (infodemic) 28, 29 ; and iv. the dissemination of false and unscientific information (fake news) 30 . Taken together, they potentiated the negative effects of social isolation, causing fear, sadness, depression, anxiety, and sleep disturbances 31 . Additionally, the same study conducted here 25 showed that patients with chronic noncommunicable diseases (NCDs) had more difficulty accessing health services during the pandemic. These services included health care, appointment bookings, and medication. It should be noted that chronic diseases, due to their typically long-lasting nature, demand more control actions and the provision of health services 32 . As a result, the difficulties in accessing health services and the social isolation measures may have impacted on the reduction of hospital admissions and the increase in mortality from CVD. Regarding changes in the structure and functioning of health care services that may have reduced the number of admissions, we highlighted: i. the reallocation of resources (financial, human and material) to assist in cases of COVID-19, which may result in the depletion of these resources for other sectors 33 ; ii. the rescheduling of appointments with greater delay; iii. the preference for assistance via telemedicine 14, 34 ; iv. reducing the daily working hours of services, health professionals and the number of daily appointments 35 . On the other hand, following the increase in COVID-19 cases in the country, there was an increase in in-hospital mortality due to CVD, as also observed in previous studies in Brazil 36 and in other countries 37, 38 . In these studies, patients hospitalized with acute myocardial infarction 37 , coronary artery disease 38, 39 , or acute cardiac injury 39 were more likely to have fatal outcomes when co-infected with SARS-CoV-2. Furthermore, this aggravating factor and the increased demand for health professionals may also explain the increase in the average cost per hospitalization observed in our study. More recently, COVID-19 started to be described in the scientific literature as a vascular disease, rather than respiratory disease, which increases the risk of pathophysiological interaction with CVD 40 . This interaction and the consequences of the Otherwise, a more homogeneous distribution of health resources among municipalities in the South region, with a greater offer of ICU beds, respirators, and health professionals in the territory can directly contribute to a better compatibility between hospital supply and demand 45 . Notably, these regional disparities reflect the unequal development and concentration of wealth in the South and Southeast regions of the country and may have influenced the lower in-hospital lethality observed in this region. In fact, population with better living conditions has more access to health care services, which implies greater survival when compared to other populations without the same access facilities. The Midwest region, which was impacted later with the arrival of COVID-19, had an average of 2.5 hospital beds/10,000 inhabitants (about 8.5% of the total number of beds in the country). Despite being the second largest Brazilian region in terms of land area, it is the second least populated, and has the second smallest GDP among the other regions. 46 . In this region, about 80% of the population depends on the SUS and, during the pandemic, the Midwest had the second lowest number of ICU beds in the SUS, which contributed to a smaller variation in the rate of admissions and an increase in the lethality rate intra-hospital for CVD 47 . Furthermore, a study that assessed the population's adherence to measures to restrict physical contact and spread COVID-19 across the Brazilian regions showed that the residents of the Midwest were those with the lowest adherence to virus control measures 48 Therefore, the study data suggest that the pandemic affected both health services and the dynamics of patients' demand for care. As a result, there has been a reduction in access to health services, diagnosis, and timely treatment of other diseases, including CVD. China's CDC detects a large number of new coronaviruses in the South China seafood market in Wuhan IHR procedures concerning public health emergencies of international concern (PHEIC) Human development, social vulnerability and COVID-19 in Brazil: A study of the social determinants of health Bastos Rolim Nunes BE, Feliciano do Carmo R. Airports, highways and COVID-19: An analysis of spatial dynamics in Brazil Expansion of COVID-19 within Brazil: The importance of highways Medidas de distanciamento social no controle da pandemia de COVID-19: potenciais impactos e desafios no Brasil Johns Hopkins Coronavirus Resource Center Impact of COVID-19 pandemic on care of oncological patients The Impact of the COVID-19 Pandemic on Individuals With Dementia. Caring Ages COVID-19 e doença hipertensiva no Brasil: possibilidade de uma tempestade perfeita Fatores associados ao comportamento da população durante o isolamento social na pandemia de COVID-19 Desafios e oportunidades para telessaúde em tempos da pandemia pela COVID-19: uma reflexão sobre os espaços e iniciativas no contexto brasileiro COVID-19 e sua relação com a doença cardiovascular: revisão integrativa. Saúde Coletiva (Barueri) COVID-19 e Injúria Miocárdica em UTI Brasileira: Alta Incidência e Maior Risco de Mortalidade Intra-Hospitalar Permutation tests for joinpoint regression with applications to cancer rates Isolamento social vertical X Isolamento social horizontal: os dilemas sanitários e sociais no enfrentamento da pandemia de COVID-19 The need to strengthen Primary Health Care in Brazil in the context of the COVID-19 pandemic Reduction in cardiovascular emergency admissions in Monaco during the COVID-19 pandemic Impatto della pandemia COVID-19 sui ricoveri per sindrome coronarica acuta: Revisione della letteratura ed esperienza monocentrica Hospitalizations for Chronic Disease and Acute Conditions in the Time of COVID-19 Cardiovascular disease and the impact of COVID-19 Uso dos serviços de saúde e adesão ao distanciamento social por adultos com doenças crônicas na pandemia de COVID-19, Brasil, 2020 Covid-19 no Brasil em 2020: impacto nas mortes por câncer e doenças cardiovasculares Impactos no comportamento e na saúde mental de grupos vulneráveis em época de enfrentamento da infecção COVID-19: revisão narrativa Infodemia: excesso de quantidade em detrimento da qualidade das informações sobre a COVID-19 As Implicações Psicológicas Desencadeadas pelo Excesso de Informações em Tempos de Pandemia Covid-19 / The Psychological Implications Triggered by the Excess of Information in Times of Pandemic Covid-19 A pandemia de COVID-19, o isolamento social, consequências na saúde mental e estratégias de enfrentamento: uma revisão integrativa A construção da vigilância e prevenção das doenças crônicas não transmissíveis no contexto do Sistema Único de Saúde Recomendações Da AMIB (Associação de Medicina Intensiva Brasileira), ABRAMEDE (Associação Brasileira de Medicina de Emergência, SBGG (Sociedade Brasileira de Geriatria e Gerontologia) e ANCP (Academia Nacional de Cuidados Paliativos) de Alocação de Recurs Qual o papel da Atenção Primária à Saúde diante da pandemia provocada pela COVID-19 The impact of COVID-19 pandemic in the management of a Vascular Surgery Department Redução na Hospitalização e Aumento na Mortalidade por Doenças Cardiovasculares durante a Pandemia Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak Subclinical coronary artery disease in COVID-19 patients Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis COVID-19 -A vascular disease Deslocamentos para Busca a Serviços de Saúde. Mapa interativo Acesso e cobertura da Atenção Primária à Saúde para populações rurais e urbanas na região norte do Brasil. Saúde em Debate Colapso na Saúde em Manaus : o fardo de não aderir às medidas não farmacológicas de redução da transmissão da COVID-19. Scielo Prepr Pandemia por COVID-19 no Brasil: análise da demanda e da oferta de leitos hospitalares e equipamentos de ventilação assistida segundo diferentes cenários Inequality, geographic situation, and meanings of action in the COVID-19 pandemic in brazil Avaliação epidemiológica das regiões do Brasil na pandemia de COVID-19 Crescimento dos leitos de UTI no país durante a pandemia de Covid-19: desigualdades entre o público x privado e iniquidades regionais Adesão às medidas de restrição de contato físico e disseminação da COVID-19 no Brasil Second wave of COVID-19 in 50 Collapse of the public health system and the emergence of new variants during the second wave of the COVID-19 pandemic in Brazil. One Heal Legend: APC: annual percentage change; AAPC: average annual percentage change ↔Stable; ↓Decreasing Legend: APC: annual percentage change; AAPC: average annual percentage change ↔Stable; ↓Decreasing Legend: APC: annual percentage change; AAPC: average annual percentage change ↔Stable; ↓Decreasing Statistical significance Legend: APC: annual percentage change; AAPC: average annual percentage change ↔Stable; ↓Decreasing Statistical significance The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.